Albuminuria-Based CKD Screening Falls Short in At-Risk Populations
Clinicians who test for albuminuria provide better evidence-based care to their patients than those who do not, research finds.
Diagnosis & Disease Information
Moderate, Severe Albuminuria Identified as Fracture Risk Factors
Study also reveals that fracture risk increases along with KDIGO risk category.
Finerenone May Lower Cardiovascular Risk in Diabetic Kidney Disease
Reduction in the risk for heart failure hospitalization appears to drive a cardiovascular benefit.
Kidney Problems Possible in Heavy Coffee Drinkers Who Metabolize Caffeine Slowly
Slow metabolizers of caffeine genetically comprise half of the Italian population.
Febuxostat for Hyperuricemia May Lower Macroalbuminuria Risk
Japanese guidelines recommend the use of urate-lowering drugs for the treatment of asymptomatic hyperuricemia.
Combination Treatment Beneficial in Albuminuric CKD
7.4 year gain in event-free survival for 50-year-old patients with combo therapy with ACEi/ARB and SGLT2 inhibitors
Personalized Screening for Kidney Disease Evaluated in Type 1 Diabetes
Compared with annual screening for urinary albumin, personalized screening can reduce time spent with undetected albuminuria, testing frequency
CKD, Albuminuria Risk Factors Identified in Childhood Cancer Survivors
Achieving normal blood pressure in childhood cancer survivors is “extremely important” for preventing CKD, according to investigators.
Albuminuria Predicts CKD Regression
Estimated glomerular filtration rate is a less reliable predictor of CKD regression, according to investigators.
eGFR Dip With Dapagliflozin Not Linked to Higher CKD Progression Risk
Understanding clinical characteristics associated with a decline in eGFR can help guide optimal use of SGLT2 inhibitors in clinical practice, according to investigators.
- Loading...
Loading...
Next post in Chronic Kidney Disease (CKD)
Loading... 
Loading...